CoreAge Rx vs SkinnyRx
Two GLP-1 desks, one scoreboard. We put CoreAge Rx and SkinnyRx head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
SkinnyRx
FDA warning letter, February 2026 — issued to Lean Rx, Inc. dba SkinnyRx. See the FDA's warning letter database.
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 58 on our six-factor Brief Score — The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
That doesn't make SkinnyRx a bad call — it's best for readers who will not inject and want a tablet at no premium over the injection, and who will check which term a "$199" is attached to before treating it as a monthly bill. Weigh the six factors below against your own priorities before you decide.
Why CoreAge Rx leads: it's our #1 here — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| CoreAge Rx | SkinnyRx | |
|---|---|---|
| Brief Score | 94/100 (A) | 58/100 (C) |
| Semaglutide | $99/mo | $349/mo month-to-month, compounded — the advertised $199 is the 12-month rung, billed as $2,388 in one payment |
| Tirzepatide | $149/mo | $399/mo month-to-month, compounded, injection or tablet at the same price — the advertised $299 is the 12-month rung, billed as $3,588 in one payment |
| Coverage | All 50 states | 47 states + Washington DC — not Alabama, Louisiana or Mississippi |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: Flat rate held for a third straight cycle — no first-month teaser to reset.
SkinnyRx: First reading, 8 August 2026. Month-to-month is $349 semaglutide and $399 tirzepatide, and the tirzepatide tablet costs exactly what the tirzepatide injection costs at all four terms. The "as low as $199 / $299" the site advertises are the twelve-month rungs, charged as $2,388 and $3,588 up front and auto-renewing annually. The separate microdose line costs the same as full dose at every shared term and floors higher, at $229 and $319, because it stops at eight months.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.